Podcast: MDS PODCAST: Defining Parkinson's disease

MDS Podcast Machine learning for drug repurposing: A novel approach to find new treatments for Parkinson’s disease

Dr. Matarazzo interviews Émeline Courtois about the recently published article on machine learning approach to discover marketed drugs that could have an impact on the development of Parkinson’s disease. Interestingly, furosemide and adrenergic drugs showed a potential protective effect in this very large cohort. Journal CME is available until January 19, 2024 Read the article.

Read More

MDS Podcast Dystonia Series: Genetic landscape of dystonia

In part 3 of the Dystonia Special Series, Dr. Francesca Morgante interviews Prof. Carolyn Sue on the Genetic landscape of dystonia.

Read More

MDS Podcast Clozapine in Parkinson’s disease: Why, when and how?

Clozapine is a antipsychotic drug that has been marketed for decades. In this interview, Dr. Friedman shares his thoughts on its utility in Parkinson’s disease along with some practical advices on how to use it in the clinic. Read the article.

Read More

MDS Podcast Off-State Dyskinesias after GDNF Infusion in Parkinson’s Disease

Sara Schaefer speaks to Alan Whone of the University of Bristol on his retrospective analysis of off-state dyskinesias in Parkinson’s disease patients who received serial infusions of GDNF into the putamen. Read the article.

Read More

MDS Podcast Dystonia Series: Pearls on diagnosis and phenomenology

In part 1 of the Dystonia Special Series, Dr. Francesca Morgante interviews Dr. Miryam Carecchio on pearls on diagnosis and phenomenology of dystonic syndrome.

Read More

MDS Podcast History of Movement Disorders: Huntington’s Disease in Venezuela

As part of the History of Movement Disorders series, Dr. Sara Schaefer and Dr. David Standaert discuss the research and humanitarian work by Nancy Wexler and team starting in the 1970s in the Venezuelan village of Barranquitas, which has the highest prevalence of Huntington’s disease in the world.

Read More